Cited by 309Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.

GFAP as a Potential Biomarker for Alzheimer’s Disease: A Systematic Review and Meta-Analysis

Open access

Kim, Ka Young, Shin, Ki Young, Chang, Keun-A·2023·Cells

DOI 10.3390/cells12091309PMC PMC10177296

Open this paper in CoChat — free account Open PDF

Abstract

Blood biomarkers have been considered tools for the diagnosis, prognosis, and monitoring of Alzheimer's disease (AD). Although amyloid-β peptide (Aβ) and tau are primarily blood biomarkers, recent studies have identified other reliable candidates that can serve as measurable indicators of pathological conditions. One such candidate is the glial fibrillary acidic protein (GFAP), an astrocytic cytoskeletal protein that can be detected in blood samples. Increasing evidence suggests that blood GFAP levels can be used to detect early-stage AD. In this systematic review and meta-analysis, we aimed to evaluate GFAP in peripheral blood as a biomarker for AD and provide an overview of the evidence regarding its utility. Our analysis revealed that the GFAP level in the blood was higher in the Aβ-positive group than in the negative groups, and in individuals with AD or mild cognitive impairment (MCI) compared to the healthy controls. Therefore, we believe that the clinical use of blood GFAP measurements has the potential to accelerate the diagnosis and improve the prognosis of AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.3390/cells12091309

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Amyloid Precursor Protein Processing and Alzheimer's Disease
O'Brien, R. J., & Wong, P. C. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113613 · Cited by 2,061
Amyloid-β and tau--a toxic pas de deux in Alzheimer’s disease
Ittner, L. M., & Götz, J. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2967 · Cited by 1,269
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
Teunissen, C. E., Verberk, I. M. W., Thijssen, E. H., Vermunt, L., Hansson, O., Zetterberg, H., van der Flier, W. M., Mielke, M. M., & del Campo, M. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00361-6 · Cited by 1,045
Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system
Hol, E. M., & Pekny, M. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.02.004 · Cited by 917
Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease
Khan, S., Barve, K. H., & Kumar, M. S. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200528142429 · Cited by 820
A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain
Wang, J., Gu, B. J., Masters, C. L., & Wang, Y.-J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.111 · Cited by 808
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
Abdelhak, A., Foschi, M., Abu-Rumeileh, S., Yue, J. K., D’Anna, L., Huss, A., Oeckl, P., Ludolph, A. C., Kuhle, J., Petzold, A., et al. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-021-00616-3 · Cited by 807
A declaração PRISMA 2020: diretriz atualizada para relatar revisões sistemáticas
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T., Mulrow, C. D., Shamseer, L., Tetzlaff, J., Akl, E. A., Brennan, S., et al. (2022) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2022.112 · Cited by 761

Flagged first, then by citations

Show all 91 references

Research works printed but not linked: 2

Page, 2022, The PRISMA 2020 statement: An updated guideline for reporting systematic reviewsDeclaracion PRISMA 2020: Una guia actualizada para la publicacion de revisiones sistematicas, Rev. Panam. Salud Publica, 46, e112
Hansen, 2022, Blood Based Biomarker for Optimization of Early and Differential Diagnosis of Alzheimer’s Dementia, Fortschr. Neurol. Psyc, 90, 326

Sorted by citations

Items 201–300 of 309

Neurofilament light chain but not glial fibrillary acidic protein serum levels are elevated in Wolfram syndrome
Jansen, M. J., Lugar, H. M., BROWN, C. M., Tang, A. F., Oiknine, L., Chen, L., Koller, J. M., Gordon, B. A., Marshall, B. A., Urano, F., et al. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1805916 · Cited by 1
Estradiol replacement abolishes cardiovascular and intracranial changes induced by a high-fat diet in menopausal female rats
Fernandes, M. V., Sá, J. M., Lopes, P. R., Sacramento, J. F., Patrício, J. S., Colombari, D. S. A., Menani, J. V., Conde, S. V., & Colombari, E. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119317 · Cited by 2
Pharmacokinetic/pharmacodynamic analyses of plasma pathophysiology biomarkers in subjects with early Alzheimer's disease following lecanemab treatment
Bhagunde, P. R., Penner, N., Willis, B. A., Bell, R. D., Sachdev, P., Charil, A., Irizarry, M. C., Hersch, S. M., & Reyderman, L. (2026) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70246 · Cited by 1
Comparison of TDP-43, NfL, and GFAP in cerebrospinal fluid and serum in Alzheimer’s disease
Manco, C., Righi, D., Sangiorgio, A. R., Pucci, B., Stefano, N. D., & Plantone, D. (2026) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-026-02253-7 · Cited by 1
Blood biomarkers of Alzheimer's disease and 15‐year decline in cognitive and motor functions in older adults
Pinardi, E., Grande, G., Ornago, A. M., Valletta, M., Rizzuto, D., Fredolini, C., Dale, M., Laukka, E. J., Mecocci, P., Winblad, B. G., et al. (2026) · Journal of Internal Medicine · doi:10.1111/joim.70110 · Cited by 1
A deep learning approach to Alzheimer’s disease classification using an improved Newton–Raphson optimizer
Emam, M. M., Salhi, A., Aldosari, F. M., Alshamrani, R. M., Althbiti, A., & Ismail, A. (2026) · Cluster Computing · doi:10.1007/s10586-025-05916-7 · Cited by 1
Glial fibrillary acidic protein (GFAP) in biofluids: analytical considerations and clinical relevance in neurodegenerative diseases
Hanin, A., Quadrio, I., Beaudeux, J., & Lamari, F. (2026) · Journal of Neurology · doi:10.1007/s00415-026-13896-w · Cited by 2
Validation of Blood-Based Biomarkers After Mild Traumatic Brain Injury with GCS 15 in a Singapore Emergency Department: An Observational Study
Kuan, W. S., Yau, Y. W., Lim, D. X. Y., Yeoh, C. K., Cheung, N. M. T., Lim, H. X. Y., & Chua, M. T. (2026) · Medicina · doi:10.3390/medicina62061095 · Cited by 1
Differential associations of plasma biomarkers with Alzheimer's disease and small vessel disease: A multimodal imaging study
Dewenter, A., Bürger, K., Janowitz, D., Paulus, M., Nuscher, B., Hirsch, F., Gesierich, B., Steward, A., Frontzkowski, L. K., Roemer, S. N., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71530 · Cited by 1
Ultrasensitive Assay Technologies
Yang, C. S.-Y., & Sabbagh, M. N. (2026) · Springer eBooks · doi:10.1007/978-3-032-23863-4_1 · Cited by 1
Emerging diagnostic biomarkers and therapeutic targets in Alzheimer's disease
Dineshbhai, T. K., Rafaliya, D., Singh, A., Maheshwari, S., Lalan, M. S., & Chakraborthy, G. S. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02341-z · Cited by 1
Okinawa-Based Nordic Diet Decreases Plasma Glial Fibrillary Acidic Protein Levels in Type 2 Diabetes Patients
Pocevičiūtė, D., Wennström, M., & Ohlsson, B. (2024) · Nutrients · doi:10.3390/nu16172847 · Cited by 1
Phenyl salicylate induces neurotoxicity and early Alzheimer's disease-like symptoms through ndrg1-regulated myelin damage, increasing bace1 in zebrafish
Liu, S., Li, X., Jiao, S., Zheng, Y., Xia, L., Núñez-Figueredo, Y., Liu, K., & Jin, M. (2025) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2025.178664 · Cited by 2
A Review of Clinical Biomarker Insights: Advances in Diagnosis and Prognosis of Early Alzheimer
Rajagopalan, R., Hariharan, S., Akshaya, N. R., & Senthamarai, R. (2025) · Global Journal of Medical Pharmaceutical and Biomedical Update · doi:10.25259/gjmpbu_38_2024 · Cited by 1
Fluid and Imaging Markers of Frontotemporal Lobar Degeneration
Prinse, F., Houwer, J. F. H. D., Dopper, E. G. P., & Seelaar, H. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_9 · Cited by 1
DPP4 valorphin activate NR4As pathway and OPA1 that protect from CoQ10 deficiency from OPA1 dysfunctions and from WMH
Tantawi, A. M. E. (2023) · Japan Journal of Clinical & Medical Research · doi:10.47363/jjcmr/2023(3)160 · Cited by 1
Early detection of Alzheimer’s disease pathophysiology using 3D virtual reality navigation: a correlational study with genetic and plasma biomarkersPreprint
Shima, S., Ohdake, R., Mizutani, Y., Tatebe, H., Koike, R., Kasai, A., Bagarinao, E., Ueda, A., Ito, M., Jun'ichi, H., et al. (2024) · medRxiv · doi:10.1101/2024.05.01.24306489 · Cited by 1
Brain Cell-based Genetic Subtyping and Drug Repositioning for Alzheimer DiseasePreprint
Sahelijo, N. J., Rajagopalan, P., Lu, Q., Rahman, R., Priyadarshi, D., Goldstein, D., Thomopoulos, S. I., Bennett, D. A., Farrer, L. A., Stein, T. D., et al. (2024) · medRxiv · doi:10.1101/2024.06.21.24309255 · Cited by 1
Age-specific control and Alzheimer’s disease reference curves and z-scores for glial fibrillary acidic protein in bloodPreprint
Halbgebauer, S., Fazeli, B., Klose, V., Nagel, G., Rosenbohm, A., Rothenbacher, D., Bachhuber, F., Jesse, S., Otto, M., Landwehrmeyer, G. B., et al. (2024) · medRxiv · doi:10.1101/2024.12.04.24318285 · Cited by 1
Clinical Performance of LucentAD Complete: A Multi-Analyte Algorithmic Blood Test for Detecting Brain Amyloid with a Scalable, Multiplexed Digital ImmunoassayPreprint
Wilson, D., Copeland, K. A. F., Vasko, A.-J., Hesterberg, L. K., Khare, M., Wolfe, M., Sheehy, P., Verberk, I. M. W., Miller, M., & Teunissen, C. E. (2025) · medRxiv · doi:10.1101/2025.03.31.25324984 · Cited by 1
Surface Problem: Unveiling Extracellular Vesicles Surface Markers and Their Implications for Central Nervous System Diseases’ Diagnosis and Treatment
Gruzdev, S., & Yakovlev, A. A. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05487-z · Cited by 1
Relationship between Topological efficiency of White Matter Structural Connectome and Plasma Biomarkers across Alzheimer's Disease ContinuumPreprint
Zhang, M., Chen, H., Huang, W., Guo, T., Ma, G., Han, Y., & Shu, N. (2023) · Research Square · doi:10.21203/rs.3.rs-3260733/v1
Quantification of blood glial fibrillary acidic protein using a second-generation microfluidic assay. Validation and comparative analysis with two established assaysPreprint
Fazeli, B., José, N. G. D. S., Jesse, S., Şenel, M., Oeckl, P., Erhart, D. K., Otto, M., Halbgebauer, S., & Tumani, H. (2023) · medRxiv · doi:10.1101/2023.08.24.23294528
Research on Alzheimer’s Disease-Related Biomarkers in the Past Five Years—CiteSpace Bibliometric Analysis Based on WOSCC Database
蒋, 静. (2023) · Statistics and Applications · doi:10.12677/sa.2023.126174
Reconsidering neurogenetic indication in the human brain: Broad expression of doublecortin transcript in hippocampal and cortical cell populationsPreprint
Kim, M., Cho, T., Kim, S. H., Lee, J. E., Kim, S. H., Kim, H. J., Hong, J.-E., Yeo, I., & Yang, H. (2024) · Research Square · doi:10.21203/rs.3.rs-4446551/v1
Immunohistochemical Detection of Axonal Injury in Chimpanzee ( Pan troglodytes ) with Traumatic and Fatal Brain Injury
Mohammadzadeh, P., Baharvand, A., Mohammadi, S., Fooladi, R., Azimi, K., & Eftekhar, E. (2024) · Macedonian Veterinary Review · doi:10.2478/macvetrev-2024-0018
Clinical Assessment of a Plasma AT(N) Panel for Alzheimer’s DiseasePreprint
Collier, B. B., Chappell, M. R., Brandon, W. C., Le, T. V., Harris, A. B., Volpe, J. M., Martone, R. L., Winslow, J. W., Boles, D., Valcour, A., et al. (2024) · medRxiv · doi:10.1101/2024.08.06.24310938
Immunity, Immunosenescence, Brain and Cognitive/Mental Health
Fülöp, T., & Witkowski, J. M. (2024) · Healthy ageing and longevity · doi:10.1007/978-3-031-68513-2_6
Noise level and no-reference-based evaluations for gamma-ray image using non-local means algorithm with CZT photon counting semiconductor detector
Lee, Y. (2024) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2024.111628
Transthyretin Levels and Instability in Alzheimer’s Disease: Correlations with AD Biomarkers in a Cohort StudyPreprint
Gião, T., Tábuas‐Pereira, M., Baldeiras, I., Saavedra, J., Dias, A., Saraiva, M. J., Almeida, M. R., Santana, I. J., & Cardoso, I. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.24.634710
Lab-on-chip arrays for diagnostic applications
Mohammadi, F., Zahraee, H., Khoshbin, Z., Abnous, K., & Taghdisi, S. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24790-3.00028-4
Identification as a Randomized Trial of Piracetam Medication on the Protein and mRNA Expressions of GFAP, Calmodulin-2, and Gelsolin in Brain Tissue of Rat Fetuses from a Pregnant-Rat Periventricular Leukomalacia Model
Aldiansyah, D., Rusdiana, R., & Camellia, V. (2025) · Journal of Reports in Pharmaceutical Sciences · doi:10.5812/jrps-151621
Blut- und liquorbasierte Biomarker der Multiplen Sklerose
Heider, T., & Mauerer, R. (2025) · Trillium Diagnostik · doi:10.47184/td.2025.01.06
Impact of Severe COVID-19 on Accelerating Dementia Onset: Clinical and Epidemiological InsightsPreprint
Mukhija, S., Sunog, M., Magdamo, C., & Albers, M. W. (2025) · medRxiv · doi:10.1101/2025.03.26.25324688
Maternal Treadmill Exercise and Zinc Supplementation Alleviate Prenatal Stress–Induced Cognitive Deficits and Restore Neurological Biomarkers in Offspring: A Study on Male Rats Aged 30 and 90 Days
Fatehfar, S., Sameei, P., Abdollahzade, N., Chodari, L., Saboory, E., & Roshan‐Milani, S. (2025) · Developmental Neurobiology · doi:10.1002/dneu.22964
Investigating Glial Fibrillary Acidic Protein Expression and Cell Morphology in a Rat Brain Following Exposure to a Weak Electromagnetic Field and Nitric Oxide Modulation During Development
Sissons, S. M., Murugan, N. J., & Dotta, B. T. (2025) · Neuroglia · doi:10.3390/neuroglia6020021
Challenges and perspectives in dementia diagnosis
Lochman, I., Novobilský, R., & Kušnierová, P. (2025) · Klinická biochemie a metabolismus · doi:10.61568/kbm.2025.007
Exploring structure-function coupling in alzheimer’s disease: bridging neuroimaging, AI, and policy for future insights
Wang, X., Jiang, Y., Dong, Y., Zhu, Q., Zhao, Y., & Zhang, S. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07389-7
Biomarkers as Outcome Measures in Clinical Trials of Alzheimer Disease
Tarawneh, R. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_15
Interruption of the Gut Integrity Contributes to Early Accumulation of Amyloid-β in the Enteric Nervous System in Rats Supplemented with a High-Fat Diet
Gawish, Z., Gamal, M., Elberry, D. A., Hegazy, E., Rashed, L. A., Hosny, S. A., Mehesen, M. N., & ShamsEldeen, A. M. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05261-1
Inflammation PET and plasma neurofilament light predict survival in people with progressive supranuclear palsyPreprint
Shapiro, N. L., Jones, P. S., Mak, E., Tsvetanov, K. A., Goddard, J., Vontobel, D. S., Durcan, R., Chouliaras, L., Fryer, T. D., Hong, Y. T., et al. (2025) · medRxiv · doi:10.1101/2025.08.27.25334139
A Comprehensive Study of Alzheimer’s Disease Biomarkers in Plasma and Cerebrospinal Fluid
Minochkin, A. K., Lobzin, V. Y., Emelin, А. Y., Kopteva, Y. P., Клиценко, О. А., Апалько, С. В., & Sherbak, S. G. (2025) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-025-01881-1
Effectiveness of Insulin-Induced umbilical cord stem cells on Seladin-1/APP/GFAP expression in rat hippocampal CA1/CA3 regions following chronic hypoxia
Hassanzadeh, G., Ashouri, S., Kargar, R., Shamosi, A., & Mahakizadeh, S. (2025) · Journal of Molecular Histology · doi:10.1007/s10735-025-10617-x
Respiratory pathogen to brain degeneration: a review of Chlamydia pneumoniae’s role in Alzheimer’s disease
Khatib, A. S., Islam, A. W., Ahmed, S. S., Zehra, S. F., & Tasnim, D. (2025) · Exploration of neuroscience · doi:10.37349/en.2025.1006111
Metabolic Trans-Omic Analysis Reveals Key Regulatory Disruption of Energy Metabolism in Alzheimer’s DiseasePreprint
Katayama, T., Sugimoto, H., Morita, K., Watanabe, H., & Kuroda, S. (2025) · eLife · doi:10.1101/2025.09.26.678758
Temporal Validation of a Plasma Diagnosis Approach for Early Alzheimer Disease Diagnosis in a Cognitive Disorder Unit
Navia, A. M., López, A., Álvarez‐Sánchez, L., Ferré‐González, L., Balaguer, Á., Baquero, M., & Cháfer‐Pericás, C. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15100475
Serum GFAP as a Potential Biomarker for Chemotherapy-Associated Cognitive Impairment in Elderly Patients with Gastrointestinal Cancers: An Exploratory Study
Tanrıverdi, Ö., & Türkçü, Ü. Ö. (2025) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-025-01323-8
Human suicide, molecular framework
Lu, D.-Y., & Wu, H. (2025) · Journal of Psychology & Clinical Psychiatry · doi:10.15406/jpcpy.2025.16.00829
Identifying a proteomics signature of cognitive impairment and dementia in blood and cerebrospinal fluid through a mediation analysis framework
Acosta, G. T., Yang, S., Calvo-Marín, J., Moghekar, A., Kamalian, A., & Lutz, M. W. (2025) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.10.004
Expression of dementia biomarkers in Appalachian and non-Appalachian ELVO patients during thrombectomy
Anil, N., McLouth, C. J., Hazelwood, H. S., Dahlke, E., Frank, J. A., Millson, N., Al‐Kawaz, M., Harp, J. P., Cranford, W., Pahwa, S. S., et al. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1672803
Biomarkers to Personalized Therapies in Neurodegenerative Medicine
Shaik, A., Shevate, K. S., Fanai, H. L., & Chand, J. (2025) · Springer eBooks · doi:10.1007/978-981-95-3945-1_17
Cytoskeltal intermediate filaments in Tau pathology and neurodegeneration
Chinnathambi, S., & Malik, S. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.10.028
Additional file 1 of Central autonomic network dysfunction and plasma Alzheimer’s disease biomarkers in older adults
Lohman, T., Kapoor, A., Engstrom, A. C., Shenasa, F., Alitin, J. P. M., Gaubert, A., Rodgers, K. E., Bradford, D. R., Mather, M., Han, S. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26731345
Additional file 1 of Circulating small extracellular vesicles in Alzheimer’s disease: a case–control study of neuro-inflammation and synaptic dysfunction
Singh, R., Rai, S., Bharti, P. S., Zehra, S., Gorai, P. K., Modi, G. P., Rani, N., Dev, K., Inampudi, K. K., Y., V. V., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26736822
Additional file 1 of Blood levels of glial fibrillary acidic protein for predicting clinical progression to Alzheimer’s disease in adults without dementia: a systematic review and meta-analysis protocol
Nihashi, T., Sakurai, K., Kato, T., Kimura, Y., Ito, K., Nakamura, A., & Terasawa, T. (2024) · Figshare · doi:10.6084/m9.figshare.25341266
The role of biomarkers in anxiety disorders
Basirat, Z. B., Yaghoubi, F., Hadei, N., Davoodi‐Dehaghani, F., Basirat, A. M. B., & Mousavi, B. (2025) · The Neuroscience Journal of Shefaye Khatam · doi:10.61882/shefa.13.3.115
TREM2 in Alzheimer's disease: A global bibliometric analysis of research evolution and therapeutic implications
Cui, L., Yue, Z., Sun, C., & Shao, K. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251411528
Proteins as Candidates for the Neurodegeneration Biomarkers
Бокша, И. С., Prokhorova, T. A., Savushkina, O. K., Терешкина, Е. Б., Vorobyeva, E. A., & Burbaeva, G. S. (2025) · Neurochemical Journal · doi:10.1134/s1819712425700631
Early functional changes and plasma GFAP in Swedish families with Autosomal Dominant Alzheimer’s disease mutations
Luckett, E. S., Zapater‐Fajarí, M., Almkvist, O., Johansson, C., Chiotis, K., Bucci, M., Wall, A. E., Ashton, N. J., Blennow, K., Zetterberg, H., et al. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-03829-6 · Cited by 1
Reduced Plasma Aβ Peptides but Stable NfL and GFAP in Major Depressive Disorder
Fernández-Ceballos, M. D. L. Á., Vidal-Nogueira, L., Fernández-Pereira, C., Fortes-González, P., Salgado‐Barreira, Á., Ledo-Matos, E., Santana-Muriel, E., Baltanás, T. R., Olivares, J. M., Veiga, C., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031474
Spatial amyloid–informed multimodal brain age as an early marker of Alzheimer’s-related vulnerability and risk stratification
Cui, L., Wang, Q.-M., Zhang, Z., Wang, M., Tu, Y.-Y., Jiang, J., Guan, Y., Li, Y.-H., Xie, F., & Guo, Q.-H. (2026) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2026.100501
Glial Fibrillary Acidic Protein: A Potential Therapeutic Target for Migraine
Liao, L., Luo, S., Zeng, Z., Luo, Y., & Mao, F. (2026) · World Journal of Clinical Medicine · doi:10.57237/j.wjcm.2026.01.001
Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Hereditary Transthyretin Amyloidosis Polyneuropathy
Loser, V., Benkert, P., Vicino, A., Ghika, N., Lim-Dubois-Ferriere, P., Daigneault, C., Küntzer, T., Maceski, A. M., Kühle, J., & Théaudin, M. (2026) · Journal of the Peripheral Nervous System · doi:10.1111/jns.70104
Single-cell machine learning uncovers genetically anchored, cell-type specific programs of Alzheimer’s diseasePreprint
Madduri, A. V., Ellis, R. J., Lakhani, C. M., Bennett, D. A., & Patel, C. J. (2026) · medRxiv · doi:10.64898/2026.01.31.26345282
GFAP and the genetic code of astrocyte activation in Alzheimer’s disease
Upadhyay, R., Srinivasan, T. B., Umapriya, R., Chandrapragasam, V., & Sevanan, M. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.01.007
Cognitive Function and Neurodegenerative Blood Biomarkers in an Aging Indian Population: Insights From LASI ‐ DAD Wave 2
Rao, A. R., Pradhan, R., Anwar, M., Gupta, A., Bhagwasia, M., Nichols, E., Gross, A. L., Thyagarajan, B., Hu, P., Crimmins, E. M., et al. (2026) · Journal of the American Geriatrics Society · doi:10.1111/jgs.70339
Human Neurotoxicity of Trichloroethylene: A Biomarker Approach
Tutkun, L., Gündüzöz, M., Büyükşekerci, M., Özakıncı, O. G., Abuşoğlu, G., Polat, M., İritaş, S. B., Türksoy, V. A., & Tutkun, E. (2026) · Journal of Applied Toxicology · doi:10.1002/jat.70116
WS 2 Nanosheet Quenched Erbium Doped NaYF 4 Upconversion Immunoprobe for the Detection of Glial Fibrillary Acidic Protein: Prognostic Biomarker of Alzheimer's Disease in Serum
Abraham, M. K., Indongo, G., Rajeevan, G., Arathy, B. K., Dhahir, D. M., & George, S. (2026) · ChemNanoMat · doi:10.1002/cnma.202500738
Cerebrospinal fluid amyloid-β 42/40 ratio is associated with ganglion cell-inner plexiform layer thinning in individuals with and without amyloid pathology
Patel, H., Choi, A., Weng, P. J., Karl, J. J., Joseph, S., Johnson, K. G., Berger, M., Whitson, H. E., Grewal, D. S., & Fekrat, S. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261423968
Age-related alterations in plasma biomarkers of relevance to Alzheimer's disease are attenuated in KLOTHO KL-VS heterozygotes
Driscoll, I. F., Wilson, R. E., Johnson, S. C., Asthana, S., Gallagher, C. L., Hermann, B. P., Sager, M. A., Carlsson, C. M., Blennow, K., Zetterberg, H., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261422411
Plasma glial fibrillary acidic protein as a potential biomarker for differentiating amyloid-negative subjective cognitive decline and mild cognitive impairment
Yoon, B. W., Lee, H.-J., Chae, H., Oh, E., Hong, Y. A., Jeong, J. H., Park, K. H., Kim, S., Wang, M. J., Choi, S. H., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261427806
Glial molecular signatures as a liquid biopsy marker in Alzheimer’s disease diagnosis
Yadav, K., & Tiwari, S. S. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.02.001
Diagnostic Blood-Based Biomarkers of Amyloid-β and Tau Pathologies Prior to Alzheimer’s Disease Diagnosis: a Rapid Umbrella Review
Yousefzadeh, N., Sharma, O., Oliver, A., O'Keefe, H., Robertson, E. G., Harris, B., Spiers, G., & Craig, D. (2026) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-026-02319-6
Plasma chaperone-mediated autophagy associated protein HSPA8 combined with white matter hyperintensities serves as the predictive marker of early-stage Alzheimer’s disease
Yan, X., Liang, C., Zhou, Y., Hong, G., Li, C., Wang, K., Huang, Y., & Xiao, X. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1753692
A metabolic–glial plasma signature defines early Alzheimer's disease: Insights from an understudied cohort
Santos, L. T. R., Costa, F. L., Rosa, I. D., Frota, A. F., Bezerra, J. R., Soares, M. V. R., Barbosa, C. D. S. N., Farias, J. W. F., da Silva, L. R. A. M., Gonçalves, P. V. D. S., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261441581
Glyceraldehyde-induced metabolic defects in cortical astrocytes: implication for Alzheimer's disease pathogenesis and therapy
Piccirillo, S., Preziuso, A., Serfilippi, T., Terenzi, V., Castaldo, P., Lariccia, V., Secondo, A., & Magi, S. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119473
Study on the Mechanism of PSMC6 Gene in Alzheimer’s Disease Based on circRNA-miRNA-mRNA Regulatory Network Analysis
Yang, X., Wang, D. X., Guo, X. Y., Liu, Y. W., & Liu, H. Y. (2026) · Russian Journal of Genetics · doi:10.1134/s1022795426700122
Multimodal integration of neuroimaging, transcriptomics and single-cell analysis reveals molecular correlates linking osteoporosis to brain abnormalities
Fang, M., Li, N., Xu, W.-Y., Xue, Y., Wang, R., & Zhou, J.-M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1817475
Stage-dependent dynamics of neuroinflammation across the Alzheimer’s continuum
Yu, R., Suraev, A. S., Shi, L., Martins, R. N., Drummond, E., Kong, S., Bassett, K., Naismith, S. L., & Michaelian, J. C. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106823
Indoleamine 2,3-dioxygenase 1 (IDO1) promoted the activation of inflammatory response in the brain tissue of Alzheimer’s disease mice by regulating NF-κB pathway
Xu, X., Wang, Q., Wang, L., Cheng, W., Li, F., Liu, H., & Guo, Y. (2026) · Neuroscience Letters · doi:10.1016/j.neulet.2026.138635
Differential associations of core and non-core plasma biomarkers with cognitive performance in Black adults
Zhu, Y., Trani, J., Walker, A. I. B., Bekena, S., Singh, R. K., & Babulal, G. M. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261450646
Effects of a 24-week intervention with freeze-dried blueberries on brain health in older adults: A randomized double-blind, placebo-controlled trial
Guardino, E. T., Gabriel, O., Mukamal, K. J., & Djoussé, L. (2026) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2026.103377
A study on the effects of CCRT on cognitive function and blood biomarkers in community-dwelling older adults with MCI
Tan, Z., Ping, J., Zhang, H., Zhang, Y., Kong, C., Lu, Y., Liu, B. A., Jiang, T., & Liu, X. (2026) · BMC Geriatrics · doi:10.1186/s12877-026-07730-1
The complement system in Alzheimer’s disease: evaluating biomarker potential in a complex neuroimmune context
Soni, H., Sutherland, G. T., & Hofer, M. J. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03927-8
Patient cerebral organoids capture Alzheimer’s disease proteomic biomarkers and drug targetsPreprint
Thomson, S., Li, X. C., Walker, S., Tang, T. C. Y., Graham, M. E., Olechnowicz, S. W. Z., Bowden, R. J., Waugh, K. A., Slawson, C. M., Burns, J. M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.22.733874
Analytical Performance and Evaluation in Clinical Cohorts of a Fully Automated Immunoassay for Plasma Glial Fibrillary Acidic Protein
Schlichtmann, B. W., Arslan, B., Johnson, K., Patzlaff, J. S., Unruh, D. J., Szabo, M., Holland, M., Todtleben, J. C., Salvati, M., Tan, K., et al. (2026) · Diagnostics · doi:10.3390/diagnostics16132060
Study of pTau217 and GFAP Levels in Iraqi Male and Female Parkinson's Patients
Al-Azawee, R. M., H.Al-Qazzaz, A., Alsaedy, A. M., & Al-Rubaei, Z. M. (2026) · Journal of the Faculty of Medicine Baghdad · doi:10.32007/jfacmedbaghdad3301
Diagnostic Value of Neurofilament Light Chain and Glial Fibrillary Acidic Protein in Differentiating Primary From Serious Secondary Headache
Camerin, S.-J., Atila, C., Blum, C. A., Sandgren, S., Maleska, A., Papadopoulou, A., Kühle, J., Mira, K., & Christ‐Crain, M. (2026) · European Journal of Neurology · doi:10.1111/ene.70691
ProLM: a plasma proteomics pretrained model for the general population
Qiu, S., Zhao, M. H., Chen, X. T., ZHANG, Z., You, H., Sun, X., Guo, J., Liang, H., Guo, Y., Chen, L., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-75507-6
Biomarkers associated with blood–brain interface regulation and relationships to exercise and epilepsy: a brief review
Diggs, M. D., Ballmann, C. G., Houston, J. T., & Allendorfer, J. B. (2026) · Frontiers in Rehabilitation Sciences · doi:10.3389/fresc.2026.1870241
Relation of fluid neurodegeneration biomarkers with white matter integrity in Alzheimer's disease patients in Latin America
Magalhães, T. N. C., Casseb, R. F., Moraes, A. S., Teixeira, C. V. L., Carletti, A. M., de Rezende, T. J. R., Joaquim, H. P. G., Talib, L. L., Forlenza, O., Cendes, F., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261467065
The activation of glial cells in the medulla visceral zone impairs synaptic plasticity and promotes inflammation and immune disorders in sepsis
Wang, J., Wang, L., Jiang, W., Zhu, L., & Li, H. (2026) · Translational Neuroscience · doi:10.1515/tnsci-2025-0398
Neuropsychological Health in Mixed Martial Arts Fighters and Combat Sport Athletes: A Scoping Review
Stern, L., Sanders, G. J., Peacock, C. A., & António, J. (2026) · Cureus · doi:10.7759/cureus.113414
Worry and Anxiety in the Era of Early Diagnosis and Disease Modifying Treatment for Alzheimer’s Disease
Stites, S. D., Lee, K., Kuz, C., Mandell, D. S., Bogner, H. R., & Brown, R. T. (2026) · Current Psychiatry Reports · doi:10.1007/s11920-026-01704-1
Sensitive quantitation of glial fibrillary acidic protein in human plasma and cerebrospinal fluid: Validation of single-molecule assay detection method
Tan, J., Wang, K., Song, H., Zhang, N., & Lin, Z. J. (2026) · NeuroMarkers. · doi:10.1016/j.neumar.2026.100235
Cell Death in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets
Li, T., Zhang, Q., Wu, Y., & Huang, R. (2026) · MedComm · doi:10.1002/mco2.70915
A Cross-Region Meta-Analysis and Machine Learning Identifies a 37-Gene Signature Associated with Alzheimer’s Disease
Shah, K. C., Littlestone, E. D., Ahmmad, M. R., Wang, C., Xu, Y., & Zhang, X. (2026) · Biomedicines · doi:10.3390/biomedicines14092032
Profiling proteome-level amino acid substitutions in Alzheimer’s disease brain tissuePreprint
Zhao, P., Lai, S., Dai, S., Zhou, C., Li, N., & Yu, W. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.08.750259
CSF neuroinflammatory biomarkers are associated with amyloid-β42/40, tau pathology, and cognitive impairment across the Alzheimer’s disease spectrum
Alruwaili, M., Turkistani, A. A., Shilbayeh, S. A. R., Mirdad, D. S. A., Almulhim, M. F., Alnaaim, S., Almubarak, M., & Initiative, A. D. N. (2026) · Immunologic Research · doi:10.1007/s12026-026-09848-1
Therapeutic Administration of Malva parviflora Hydroalcoholic Extract Restores Cognitive Function Consistent with a Resilient Phenotype in Female 5XFAD
Rojas-Sánchez, I., Cortes-Flores, E., Camacho‐Concha, N., Almazán, J. L., Ramı́rez-Lugo, L., Crivelli-Galindo, E., Ramírez-Serrano, C. E., Pedraza‐Alva, G., & Pérez‐Martínez, L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198665

Authors: Kim, K. Y., Shin, K. Y., & Chang, K.-A.
Affiliations: Gachon University (KR)
Seoul National University (KR)
Corresponding author: Shin, Ki Young
Chang, Keun-A
ORCID: Kim, Ka Young
Shin, Ki Young
Chang, Keun-A
Venue: Cells
Publisher: MDPI AG
Published: 2023-05-04
Volume: 12
Issue: 9
Pages: 1309
ISSN: 2073-4409 (ISSN-L)
DOI: 10.3390/cells12091309
PMC: PMC10177296
OpenAlex: W4376630140
Cited by: 309
References: 91
Citations by year: 2026: 93 · 2025: 126 · 2024: 80 · 2023: 10
FWCI: 14.11
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (vor)
Locations: Cells (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders: National Research Foundation of Korea (NRF) (2022R1A2C1092597, 2020R1I1A1A01070793)
Basic Science Research Program through the NRF of Korea (2022R1A2C1092597, 2020R1I1A1A01070793)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: glial fibrillary acidic protein, Alzheimer's disease, blood biomarkers, peripheral blood, amyloid-beta, mild cognitive impairment, early diagnosis, prognosis, astrocytes
MeSH terms: Alzheimer Disease, Glial Fibrillary Acidic Protein, Humans, Biomarkers, Amyloid beta-Peptides, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

GFAP as a Potential Biomarker for Alzheimer’s Disease: A Systematic Review and Meta-Analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks